Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Moves On From U.K. Health Food Retail Misadventure

This article was originally published in The Tan Sheet

Executive Summary

Less than four years after acquiring U.K. chain Julian Graves as a platform for European growth, NBTY absorbs a $20 mil. charge to get rid of the subsidiary, which had “continuing operating losses.” NBTY plans to refocus resources on Holland & Barrett and its other European supplement retailers.

You may also be interested in...



NBTY Acquires Balance Bar To Expand In Sports Category

The acquisition from private equity firm Brynwood Partners includes four product lines under the Balance Bar brand, which NBTY claims is one of the most recognizable in the nutrition bar category, a growing sector where the firm already has a sizable presence.

NBTY Acquires Balance Bar To Expand In Sports Category

The acquisition from private equity firm Brynwood Partners includes four product lines under the Balance Bar brand, which NBTY claims is one of the most recognizable in the nutrition bar category, a growing sector where the firm already has a sizable presence.

Brand-Boosting Schiff Nutrition Sees Upside In Top-Selling Supplements

Schiff Nutrition CEO Tarang Amin, a veteran of managing brands for Clorox and P&G, sees additional upside in top-selling brands such as MegaRed and Move Free. The firm also is de-emphasizing its struggling private label business.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel